Evidence map›Paper›PMID 41280903›Full record

ArticleFrontiers in immunology2025

A fingerprint approach to pioneer structure-based T cell receptor repertoire analysis and specificity prediction.

Francesca Mayol-Rullan, Marine Bugnon, Marta A S Perez, Vincent Zoete

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesca Mayol-RullanComputer-aided Molecular Engineering Group, Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Epalinges, Switzerland.
Marine BugnonComputer-aided Molecular Engineering Group, Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Epalinges, Switzerland.
Marta A S PerezComputer-aided Molecular Engineering Group, Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Epalinges, Switzerland.
Vincent ZoeteComputer-aided Molecular Engineering Group, Department of Fundamental Oncology, Lausanne University, Ludwig Institute for Cancer Research, Epalinges, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The development of cancer immunotherapy has accelerated in recent years. Understanding the specificity of T cell receptors (TCR) for peptides presented by the major histocompatibility complex (pMHC) is a critical step towards improving immunotherapy approaches, such as adoptive cell transfer and peptide vaccination. Despite notable computational advances, the unambiguous pairing of TCR with pMHC, from pools of thousands of candidates and unseen pMHC, remains elusive. Methods: To meet this challenge and showcase the potential of using physics-based structure-based methods without being hindered by their computational cost, we developed a novel approach, TCRfp. This method transforms the 3D structure of TCRs into one-dimensional structural fingerprints (FPs) using the electroshape 5D (ES5D) technique. Results: We have modelled more than 15'000 3D structures of paired TCR alpha and beta chains with known sequences and pMHC specificity and encoded them into 1D TCRfp. Anticipating future clinical applications, we have translated the TCR modelling process into a fast pipeline. Similarity measures between TCR FPs correlate with their ability to recognize similar or identical epitopes within both the training set and in the external validation sets. Discussion: TCRfp constitutes a rapid approach for high-throughput TCR comparison and repertoire analysis based on molecular 3D structures. When tested on a private dataset and combined with a basic sequence-based method via logistic regression, TCRfp surpassed existing approaches in predicting TCR specificities. TCRfp represents a structurally informed complement to sequence-based approaches and could enhance our ability to decode immune recognition.

Indexed as

Receptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaComputational BiologyHumansMajor Histocompatibility ComplexModels, MolecularPeptidesProtein ConformationPeptidesReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-beta3D structureantigenfingerprintsspecificityT cell receptor (TCR)

Identifiers

PMID41280903
PMCPMC12634567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.